Escalating Dose Study in Healthy Volunteers With SEN0014196

NCT01521832 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Huntington's Disease

Interventions

DRUG: SEN0014196
DRUG: SEN0014196
DRUG: SEN0014196
DRUG: SEN0014196
DRUG: SEN0014196
DRUG: SEN0014196
DRUG: SEN0014196
DRUG: SEN0014196
DRUG: SEN0014196
DRUG: SEN0014196
DRUG: SEN0014196

Sponsor

Siena Biotech S.p.A.